Content area experts as authors: helpful or harmful for systematic reviews and meta-analyses?
暂无分享,去创建一个
[1] John P A Ioannidis,et al. Primary study authors of significant studies are more likely to believe that a strong association exists in a heterogeneous meta-analysis compared with methodologists. , 2012, Journal of clinical epidemiology.
[2] P. Gøtzsche. Mammography screening: truth, lies, and controversy , 2012, The Lancet.
[3] Peter C Gøtzsche,et al. Why we need easy access to all data from all clinical trials and how to accomplish it , 2011, Trials.
[4] J. Ioannidis,et al. Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. , 2011, JAMA.
[5] A. Scialli,et al. Promotional Tone in Reviews of Menopausal Hormone Therapy After the Women's Health Initiative: An Analysis of Published Articles , 2011, PLoS medicine.
[6] P. Gøtzsche,et al. General health checks for reducing morbidity and mortality from disease , 2011 .
[7] Laura A. Levit,et al. Finding what works in health care : standards for systematic reviews , 2011 .
[8] A. Fugh-Berman,et al. The Haunting of Medical Journals: How Ghostwriting Sold “HRT” , 2010, PLoS medicine.
[9] J. Ioannidis,et al. Partisan Perspectives in the Medical Literature: A Study of High Frequency Editorialists Favoring Hormone Replacement Therapy , 2010, Journal of General Internal Medicine.
[10] Amy T. Wang,et al. Association between industry affiliation and position on cardiovascular risk with rosiglitazone: cross sectional systematic review , 2010, BMJ : British Medical Journal.
[11] J. Ioannidis,et al. Persistent reservations against contradicted percutaneous coronary intervention indications: citation content analysis. , 2009, American heart journal.
[12] Veronica Yank,et al. Financial ties and concordance between results and conclusions in meta-analyses: retrospective cohort study , 2007, BMJ : British Medical Journal.
[13] J. Ioannidis,et al. Percutaneous Coronary Intervention Versus Conservative Therapy in Nonacute Coronary Artery Disease: A Meta-Analysis , 2005, Circulation.
[14] J. Ioannidis,et al. Better Reporting of Harms in Randomized Trials: An Extension of the CONSORT Statement , 2004, Annals of Internal Medicine.
[15] Christopher Martyn,et al. A Short History of Nearly Everything , 2003, BMJ : British Medical Journal.
[16] H. Ullum,et al. Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data , 2001, Annals of Internal Medicine.
[17] A. Zietman,et al. Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer. , 2000, JAMA.
[18] L. Opie. Conflict of interest in the debate over calcium-channel antagonists. , 1998, The New England journal of medicine.
[19] G. Guyatt,et al. The Science of Reviewing Research a , 1993, Annals of the New York Academy of Sciences.
[20] F. Mosteller,et al. A comparison of results of meta-analyses of randomized control trials and recommendations of clinical experts. Treatments for myocardial infarction. , 1992, JAMA.
[21] David M. Eddy,et al. Meta-analysis by the confidence profile method , 1992 .